| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 2956 | 2019 |
| Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus MJ Roman, BA Shanker, A Davis, MD Lockshin, L Sammaritano, ... New England Journal of Medicine 349 (25), 2399-2406, 2003 | 1764 | 2003 |
| Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE J Tian, AM Avalos, SY Mao, B Chen, K Senthil, H Wu, P Parroche, ... Nature immunology 8 (5), 487-496, 2007 | 1667 | 2007 |
| Activation of the interferon‐α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease KA Kirou, C Lee, S George, K Louca, MGE Peterson, MK Crow Arthritis & Rheumatism 52 (5), 1491-1503, 2005 | 762 | 2005 |
| Identification of a central role for complement in osteoarthritis Q Wang, AL Rozelle, CM Lepus, CR Scanzello, JJ Song, DM Larsen, ... Nature medicine 17 (12), 1674-1679, 2011 | 657 | 2011 |
| Type I interferon in the pathogenesis of lupus MK Crow The Journal of Immunology 192 (12), 5459-5468, 2014 | 592 | 2014 |
| High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus TB Niewold, J Hua, TJA Lehman, JB Harley, MK Crow Genes & Immunity 8 (6), 492-502, 2007 | 492 | 2007 |
| Coordinate overexpression of interferon‐α–induced genes in systemic lupus erythematosus KA Kirou, C Lee, S George, K Louca, IG Papagiannis, MGE Peterson, ... Arthritis & Rheumatism 50 (12), 3958-3967, 2004 | 480 | 2004 |
| Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus W Yang, N Shen, DQ Ye, Q Liu, Y Zhang, XX Qian, N Hirankarn, D Ying, ... PLoS genetics 6 (2), e1000841, 2010 | 458 | 2010 |
| Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis AD Pearle, CR Scanzello, S George, LA Mandl, EF DiCarlo, M Peterson, ... Osteoarthritis and cartilage 15 (5), 516-523, 2007 | 456 | 2007 |
| Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. M Koshy, D Berger, MK Crow The Journal of clinical investigation 98 (3), 826-837, 1996 | 433 | 1996 |
| Arterial stiffness in chronic inflammatory diseases MJ Roman, RB Devereux, JE Schwartz, MD Lockshin, SA Paget, A Davis, ... Hypertension 46 (1), 194-199, 2005 | 416 | 2005 |
| Preclinical carotid atherosclerosis in patients with rheumatoid arthritis MJ Roman, E Moeller, A Davis, SA Paget, MK Crow, MD Lockshin, ... Annals of internal medicine 144 (4), 249-256, 2006 | 412 | 2006 |
| Interferon target-gene expression and epigenomic signatures in health and disease FJ Barrat, MK Crow, LB Ivashkiv Nature immunology 20 (12), 1574-1583, 2019 | 395 | 2019 |
| Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti–RNA binding protein autoantibodies J Hua, K Kirou, C Lee, MK Crow Arthritis & Rheumatism 54 (6), 1906-1916, 2006 | 369 | 2006 |
| Lymphocyte transformation induced by autologous cells. IV. Human T-lymphocyte proliferation induced by autologous or allogeneic non-T lymphocytes. MM Kuntz, JB Innes, ME Weksler The Journal of experimental medicine 143 (5), 1042-1054, 1976 | 356 | 1976 |
| CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. EJ Schattner, KB Elkon, DH Yoo, J Tumang, PH Krammer, MK Crow, ... The Journal of experimental medicine 182 (5), 1557-1565, 1995 | 338 | 1995 |
| Microarray analysis of interferon-regulated genes in SLE MK Crow, KA Kirou, J Wohlgemuth Autoimmunity 36 (8), 481-490, 2003 | 335 | 2003 |
| Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? CR Scanzello, A Plaas, MK Crow Current opinion in rheumatology 20 (5), 565-572, 2008 | 322 | 2008 |
| Association of the IRF5 risk haplotype with high serum interferon‐α activity in systemic lupus erythematosus patients TB Niewold, JA Kelly, MH Flesch, LR Espinoza, JB Harley, MK Crow Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 317 | 2008 |
